Search Within

Joachim Yahalom

  1. "Owen O'connor"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (5)
Groups
  1. Center for Hematologic Malignancies (10)
  2. Department of Medicine (10)
  3. Hematologic Malignancies, Division of (10)
  4. Lymphoma (10)
  5. Radiation Oncology, Department of (10)
  6. Survivorship Research (10)

More Groups

People
  1. Andrew Zelenetz (10)
  2. Ariela Noy (10)
  3. Carol Portlock (10)
  4. Craig Moskowitz (10)
  5. David Straus (10)
  6. Owen O'connor (10)

More People

Years
  1. 2010 (1)
  2. 2005 (2)
  3. 2004 (4)
  4. 2003 (2)
  5. 2001 (1)
Publications
  1. Blood (5)
  2. British Journal of Haematology (3)
  3. Journal of Clinical Oncology (1)
  4. Leukemia and Lymphoma (1)
Publishers
  1. American Society of Hematology (5)
  2. John Wiley & Sons (3)
  3. American Society of Clinical Oncology (1)
  4. Taylor & Francis Group (1)

Results (10)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • High-dose chemo-radiotherapy for relapsed or refractory Hodgkin lymphoma and the significance of pre-transplant functional imaging: Research paper
    Journal Article

    Moskowitz, C. H.; Yahalom, J.; Zelenetz, A. D.; Zhang, Z.; Filippa, D.; Teruya-Feldstein, J.; Kewalramani, T.; Moskowitz, A. J.; Rice, R.; Maragulia, J.; more...
    British Journal of Haematology (2010)

    Fulltext@MSK | Save
  • Primary mediastinal large B-cell lymphoma: Optimal therapy and prognostic factor analysis in 141 consecutive patients treated at Memorial Sloan Kettering from 1980 to 1999
    Journal Article

    Hamlin, P. A.; Portlock, C. S.; Straus, D. J.; Noy, A.; Singer, A.; Horwitz, S. M.; Oconnor, O. A.; Yahalom, J.; Zelenetz, A. D.; Moskowitz, C. H.
    British Journal of Haematology (2005)

    Fulltext@MSK | Save
  • R-CHOP-14 in patients with diffuse large B-cell lymphoma: Feasibility and preliminary efficacy
    Journal Article

    Halaas, J. L.; Moskowitz, C. H.; Horwitz, S.; Portlock, C.; Noy, A.; Straus, D.; O'Connor, O. A.; Yahalom, J.; Zelenetz, A. D.
    Leukemia and Lymphoma (2005)

    Fulltext@MSK | Save
  • Primary Mediastinal Large B cell Lymphoma: Elucidating optimal therapy and prognostic factors; an analysis in 141 consecutive patients treated at Memorial Sloan Kettering from 1980-1999
    Meeting Abstract

    Hamlin, P. A.; Portlock, C. S.; Straus, D. J.; Noy, A.; Horwitz, S. M.; O'connor, O.; Yahalom, J.; Zelenetz, A. D.; Moskowitz, C. H.
    Blood (2004)

    Fulltext@MSK | Save
  • Feasibility and preliminary efficacy of R-CHOP-14 in patients with diffuse large B-cell lymphoma (DLBCL)
    Meeting Abstract

    Halaas, J. L.; Moskowitz, C. H.; Noy, A.; Portlock, C.; Horwitz, S.; Straus, D.; O'connor, O.; Yahalom, J.; Zelenetz, A. D.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Adverse prognostic significance of CD20 positive Reed-Sternberg cells in classical Hodgkin's disease
    Journal Article

    Portlock, C. S.; Donnelly, G. B.; Qin, J.; Straus, D.; Yahalom, J.; Zelenetz, A.; Noy, A.; O'connor, O.; Horwitz, S.; Moskowitz, C.; more...
    British Journal of Haematology (2004)

    Fulltext@MSK | Save
  • Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma
    Journal Article

    Kewalramani, T.; Zelenetz, A. D.; Nimer, S. D.; Portlock, C.; Straus, D.; Noy, A.; O'connor, O.; Filippa, D. A.; Teruya-Feldstein, J.; Gencarelli, A.; more...
    Blood (2004)

    Fulltext@MSK | Save
  • Stanford V and radiotherapy for advanced and locally extensive Hodgkin's disease (HD): The memorial Sloan-Kettering Cancer Center (MSKCQ) experience
    Meeting Abstract

    Yahalom, J.; Edwards-Bennett, S.; Jacobs, J.; Moskowitz, C. H.; Wu, E. J.; Cotler, M.; Horwitz, S. M.; Noy, A.; O'Connor, O. A.; Portlock, C. S.; more...
    Blood (2003)

    Fulltext@MSK | Save
  • Risk-adpated high dose chemoradiotherapy and ASCT for patients with relapsed and primary refractory Hodgkin's disease: An intent to treat analysis
    Meeting Abstract

    Moskowitz, C. H.; Kewalramani, T.; Nimer, S. D.; Rice, R. D.; Rosenzweig, L.; Horwitz, S.; Noy, A.; O'connor, O.; Portlock, C. S.; Straus, D.; more...
    Blood (2003)

    Fulltext@MSK | Save
  • Rituximab significantly increases the complete response rate in patients with relapsed or primary refractory DLBCL receiving ICE as second-line therapy (SLT)
    Meeting Abstract

    Kewalramani, T.; Zelenetz, A.; Bertino, J.; Donnelly, G.; Hedrick, E.; Noy, A.; O'connor, O.; Portlock, C.; Straus, D.; Yahalom, J.; more...
    Blood (2001)

    Fulltext@MSK | Save